![Peter DeMuth](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Peter DeMuth
Technik-/Wissenschafts-/F&E-Leiter bei ELICIO THERAPEUTICS, INC.
Vermögen: - $ am 31.05.2024
Aktive Positionen von Peter DeMuth
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
ELICIO THERAPEUTICS, INC. | Technik-/Wissenschafts-/F&E-Leiter | 01.01.2022 | - |
Karriereverlauf von Peter DeMuth
Ehemalige bekannte Positionen von Peter DeMuth
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Elicio Therapeutics, Inc. (Old)
![]() Elicio Therapeutics, Inc. (Old) BiotechnologyHealth Technology Elicio Therapeutics, Inc. engages in the development of vaccines for infectious disease and cancer. Its programs focus on a novel lipid nanocapsule platform technology for delivering vaccines in a form mimicking the structure of pathogens to elicit potent immunity in prophylactic and therapeutic settings. The company was founded by Satish Jindal and Darrell Irvine on August 10, 2011 and is headquartered in Cambridge, MA. | Technik-/Wissenschafts-/F&E-Leiter | 01.08.2017 | 01.06.2023 |
Ausbildung von Peter DeMuth
Massachusetts Institute of Technology | Doctorate Degree |
University of Maryland | Undergraduate Degree |
Statistik
International
Vereinigte Staaten | 5 |
Operativ
Chief Tech/Sci/R&D Officer | 2 |
Doctorate Degree | 1 |
Undergraduate Degree | 1 |
Sektoral
Health Technology | 3 |
Finance | 2 |
Consumer Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
ELICIO THERAPEUTICS, INC. | Health Technology |
Private Unternehmen | 1 |
---|---|
Elicio Therapeutics, Inc. (Old)
![]() Elicio Therapeutics, Inc. (Old) BiotechnologyHealth Technology Elicio Therapeutics, Inc. engages in the development of vaccines for infectious disease and cancer. Its programs focus on a novel lipid nanocapsule platform technology for delivering vaccines in a form mimicking the structure of pathogens to elicit potent immunity in prophylactic and therapeutic settings. The company was founded by Satish Jindal and Darrell Irvine on August 10, 2011 and is headquartered in Cambridge, MA. | Health Technology |
- Börse
- Insiders
- Peter DeMuth
- Erfahrung